Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.4K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.4K
Detailed Structure and Function of Lymph Nodes01:23

Detailed Structure and Function of Lymph Nodes

3.8K
Lymph nodes are bean-shaped structures that cluster along the lymphatic vessels in the inguinal, axillary, and cervical regions. Each node is divided into compartments by a capsule that extends trabeculae inward.
From a histological perspective, lymph nodes can be split into two main areas: the superficial cortex and the deep medulla. The outer cortex is populated by dendritic cells, macrophages, and B lymphocytes, which are densely packed into follicles. When these B-lymphocytes are presented...
3.8K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

2.6K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.6K
Functions of the Lymphatic and Immune System01:28

Functions of the Lymphatic and Immune System

6.1K
The lymphatic system plays a crucial role in bolstering our immune system. It consists of a network of lymphoid organs, lymph, and lymphatic vessels that provide structural and functional support in safeguarding the body against pathogens such as viruses and bacteria.
The primary lymphoid organs, including the bone marrow and the thymus, serve as the maturation sites for lymphocytes. Secondary lymphoid organs, like the mucosa-associated lymphoid tissue, activate these lymphocytes and serve as...
6.1K
Introduction to Lymphatic and Immune System01:22

Introduction to Lymphatic and Immune System

16.1K
Immunity is a crucial biological concept about our body's inherent capacity to prevent infections and diseases. A complex network of cells and tissues collectively known as the immune system facilitates this natural defense mechanism. The immune system plays an integral role in maintaining our health and well-being, shielding us from potential health threats.
The immune responses can be categorized into two types: innate and adaptive. Innate immunity comprises nonspecific defenses we are...
16.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantigen mRNA-LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

POLY-Senolytic nanoplatform for tumor-specific eradication of senescent tumor cells and mitigation of radiotherapy-induced immune resistance of cancer.

Nature communications·2026
Same author

Spatiotemporal Nanotransformers for Antitumoral Orchestration of Protein Homeostasis.

Polymer science & technology (Washington, D.C.)·2026
Same author

Multivalent Antibody-Recruiting Molecules for Targeted Immune-Killing of Carbonic Anhydrase IX-Expressing Cancer Cells.

Angewandte Chemie (International ed. in English)·2026
Same author

Marker-Agnostic Tumor Anchoring Chimeras Enable pH-Gated Immune Engagement.

Angewandte Chemie (International ed. in English)·2026
Same author

Multivalent Antibody-Recruiters Targeting Fibroblast Activation Protein for Innate Immune Killing.

Biomacromolecules·2026
Same journal

Innate Immunity of Framework Nucleic Acids.

Accounts of chemical research·2026
Same journal

High-Performance CH-Series Non-Fullerene Acceptors for Organic Photovoltaics.

Accounts of chemical research·2026
Same journal

Design Principles for Negative Thermal Expansion in Two-Dimensional Materials.

Accounts of chemical research·2026
Same journal

Main Group Redox Catalysis: New Frontiers with Germanium and Tin.

Accounts of chemical research·2026
Same journal

Taming Irreversibility in sp<sup>2</sup>-Carbon-Conjugated COFs from Polycrystalline Powders to Single Crystals and Thin Films.

Accounts of chemical research·2026
Same journal

Electroactive Imidazolium Ionic Liquids in Organic Synthesis.

Accounts of chemical research·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

15.0K

Engineering Strategies for Lymph Node Targeted Immune Activation.

Yong Chen1, Stefaan De Koker2, Bruno G De Geest1

  • 1Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, 9000 Ghemt, Belgium.

Accounts of Chemical Research
|September 10, 2020
PubMed
Summary
This summary is machine-generated.

Nanoparticle vaccines enhance immune responses by targeting lymph nodes. Strategies include direct injection, dendritic cell transport, and passive lymphatic drainage, optimizing vaccine efficacy for emerging diseases and cancer immunotherapy.

More Related Videos

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.6K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.4K

Related Experiment Videos

Last Updated: Dec 9, 2025

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

15.0K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.6K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.4K

Area of Science:

  • Biomaterials and Nanotechnology
  • Immunology and Vaccine Development
  • Drug Delivery Systems

Background:

  • Developing potent, long-lasting adaptive immune responses is crucial for combating emerging pathogens and advancing cancer immunotherapy.
  • Nanoparticle carriers are advanced biomaterials explored to enhance vaccine and immunotherapy efficacy and safety by focusing payload delivery and limiting systemic distribution.
  • The effectiveness of nanoparticle vaccines is closely linked to their ability to reach and accumulate in lymph nodes, where adaptive immune responses are initiated.

Purpose of the Study:

  • To review and discuss strategies for improving nanoparticle delivery to lymph nodes for enhanced vaccine and immunotherapy outcomes.
  • To evaluate the advantages and limitations of different nanoparticle delivery methods to lymph nodes.

Main Methods:

  • Direct intranodal injection of nanoparticles.
  • Active transport via targeting peripheral dendritic cells (DCs) using ex vivo engineering or in vivo targeting of surface receptors (e.g., C-type lectin receptors).
  • Passive transport of nanoparticles through afferent lymphatic vessels by optimizing physicochemical properties (size, charge, hydrophobicity/hydrophilicity) and utilizing natural transporters like albumin.

Main Results:

  • Direct intranodal injection is effective but impractical for mass vaccination due to the need for ultrasound guidance and potential disruption of lymph node architecture.
  • Dendritic cell-mediated transport, while studied extensively, faces challenges with ex vivo procedures (laborious, complex) and in vivo migration efficiency.
  • Passive lymphatic drainage, particularly for smaller nanoparticles, offers faster and more efficient delivery to lymph nodes compared to cell-mediated transport. Albumin binding enhances transport.

Conclusions:

  • Optimizing nanoparticle physicochemical properties, especially size, is critical for efficient passive lymph node delivery.
  • Targeting dendritic cells in vivo presents a promising strategy, despite challenges with non-specific uptake.
  • Passive transport and targeted delivery strategies are key to maximizing the potential of nanoparticle vaccines and immunotherapies.